Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
9.51
+0.50 (5.55%)
Apr 7, 2026, 4:00 PM EDT - Market closed
Fortrea Holdings Employees
As of December 31, 2025, Fortrea Holdings had 14,300 total employees, including 13,871 full-time and 429 part-time employees. The number of employees decreased by 1,820 or -11.29% compared to the previous year.
Employees
14,300
Change
-1,820
Growth
-11.29%
Revenue / Employee
$190,448
Profits / Employee
-$68,965
Market Cap
889.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14,300 | -1,820 | -11.29% | 13,871 | 429 |
| Sep 30, 2025 | 14,500 | -1,000 | -6.45% | 14,500 | 0 |
| Jun 30, 2025 | 14,500 | -1,500 | -9.38% | 14,500 | 0 |
| Mar 31, 2025 | 15,000 | -1,000 | -6.25% | 15,000 | 0 |
| Dec 31, 2024 | 16,120 | -1,880 | -10.44% | 15,500 | 620 |
| Sep 30, 2024 | 15,500 | -3,500 | -18.42% | 15,500 | 0 |
| Jun 30, 2024 | 16,000 | -3,000 | -15.79% | 16,000 | 0 |
| Mar 31, 2024 | 16,000 | -2,000 | -11.11% | 16,000 | 0 |
| Dec 31, 2023 | 18,000 | 0 | - | 17,460 | 540 |
| Sep 30, 2023 | 19,000 | 1,000 | 5.56% | 19,000 | 0 |
| Jun 30, 2023 | 19,000 | - | - | 19,000 | 0 |
| Mar 31, 2023 | 18,000 | - | - | 17,370 | 630 |
| Dec 31, 2022 | 18,000 | - | - | 17,370 | 630 |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| UroGen Pharma | 291 |
| Sana Biotechnology | 142 |
| Inhibrx Biosciences | 110 |
| Cullinan Therapeutics | 109 |
| Janux Therapeutics | 109 |
| ORIC Pharmaceuticals | 104 |
| Annexon | 96 |
FTRE News
- 21 hours ago - Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials - GlobeNewsWire
- 4 weeks ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - GlobeNewsWire
- 7 weeks ago - Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - GlobeNewsWire
- 2 months ago - Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call - GlobeNewsWire
- 2 months ago - Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE - PRNewsWire
- 3 months ago - Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference - GlobeNewsWire